Mass drug administration for elimination of lymphatic filariasis: a discussion response

被引:0
|
作者
Wiwanitkit, Somsri
Wiwanitkit, Viroj
机构
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
下载
收藏
页码:182 / 182
页数:1
相关论文
共 50 条
  • [21] Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines
    Maria Lourdes E Amarillo
    Vicente Y Belizario
    Jewel T Sadiang-abay
    Stephanie Anne M Sison
    Ariane Marie S Dayag
    Parasites & Vectors, 1
  • [23] Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance
    Hussain, Mohammad A.
    Sitha, Ashok K.
    Swain, Subhashisa
    Kadam, Shridhar
    Pati, Sanghamitra
    INFECTIOUS DISEASES OF POVERTY, 2014, 3
  • [24] Mass drug administration to eliminate lymphatic filariasis in Southern India
    Pattanshetty, Sanjay
    Kumar, Ashwini
    Kumar, Ravi
    Rao, Chythra R.
    Badiger, Sanjeev
    Rashmi, R.
    Kamath, Sneha
    AUSTRALASIAN MEDICAL JOURNAL, 2010, 3 (13): : 847 - 850
  • [25] Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines
    Amarillo, Maria Lourdes E.
    Belizario, Vicente Y., Jr.
    Sadiang-abay, Jewel T.
    Sison, Stephanie Anne M.
    Dayag, Ariane Marie S.
    PARASITES & VECTORS, 2008, 1 (1)
  • [26] Mass Drug Administration (MDA) for Elimination of Lymphatic Filariasis: Experiences from Nayagarh District of Odisha, India
    Bhatia, Vikas
    Giri, Prajna Paramita
    Sahoo, Soumya Swaroop
    Preeti, P. S.
    Sahu, Dinesh Prasad
    INDIAN JOURNAL OF COMMUNITY HEALTH, 2018, 30 (03) : 287 - 292
  • [27] Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance
    Mohammad A Hussain
    Ashok K Sitha
    Subhashisa Swain
    Shridhar Kadam
    Sanghamitra Pati
    Infectious Diseases of Poverty, 3
  • [28] Community and Drug Distributor Perceptions and Experiences of Mass Drug Administration for the Elimination of Lymphatic Filariasis: A Rapid Review of Qualitative Research
    Ames, Heather Melanie R.
    Zuske, Meike
    King, Jonathan D.
    Steinmann, Peter
    Bosch-Capblanch, Xavier
    HIGHLIGHTING OPERATIONAL AND IMPLEMENTATION RESEARCH FOR CONTROL OF HELMINTHIASIS, 2019, 103 : 117 - +
  • [29] A MULTICENTER STUDY OF THE SAFETY OF TRIPLE DRUG MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS
    Weil, Gary J.
    Bogus, Joshua
    Dubray, Christine
    Fischer, Peter U.
    Jambulingam, P.
    King, Christopher L.
    Lemoine, Jean Frantz
    O'Brian, Katiuscia
    Robinson, Leanne J.
    Supali, Taniawati
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 239 - 239
  • [30] Mass Drug Administration for the Elimination of Lymphatic Filariasis - Port-au-Prince, Haiti, 2011-2012
    Streit, Thomas
    Desir, Luccene
    Oscar, Roland
    Lemoine, Jean Frantz
    Purcell, Nora Colleen
    Keller, Angela
    Lammie, Patrick J.
    Deming, Michael
    De Rochars, Valery E. Madsen Beau
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2013, 62 (23): : 466 - 468